Page 10 - Latest Updates on Q4 Results

Sun Pharma Q4 results: Net profit falls 19% to ₹2,153.9 cr, revenue up 8%

Sun Pharma posted a 19% drop in Q4 profit to ₹2,153.9 crore, while revenue rose 8.5%. India formulation sales grew 13.6%, and a ₹5.5 final dividend has been recommended

Emcure Q4 profit jumps 63%, domestic business drives 19.5% revenue rise

Emcure Pharma posted strong March quarter results with 63% rise in net profit and 19.5% growth in revenue, driven by robust domestic demand and global segment performance

Deepak Fertilisers Q4 results: PAT jumps 20.7% to ₹277 cr on higher income

Deepak Fertilisers and Petrochemicals Corporation Ltd (DFPCL) on Thursday posted a 20.74 per cent rise in consolidated net profit to Rs 277.66 crore for the fourth quarter of the 2024-25 fiscal on higher income. The company reported a net profit of Rs 229.96 crore a year ago, according to a regulatory filing. Its total income rose 26 per cent to Rs 2,716.99 crore during the January-March quarter of 2024-25, from Rs 2,158.56 crore in the year-ago period. The company's expenses remained higher at Rs 2,396.99 crore against Rs 1,862.20 crore. For the full 2024-25 fiscal, the company posted a two-fold jump in consolidated net profit to Rs 944.67 crore from Rs 467.56 crore in the previous year. The company said its strategic investments are on track. The overall progress in the TAN project in Gopalpur is at 75 per cent, and the same for the Nitric Acid project in Dahej is at 48 per cent. Bulk fertiliser manufactured sales volume in Q4 surged 68 per cent, driven by increased adoption o

Stock market crash highlights: Sensex sheds 645 pts, Nifty at 24,609; IT, FMCG, Oil & Gas top drag

Sensex Today | Stock Market Highlights on Thursday, May 22, 2025: In the broader basket, Nifty Midcap100 and Nifty Smallcap100 indices settled lower by 0.52 per cent and 0.26 per cent, respectively

Lincoln Pharma posts Rs 11.62 cr profit for Jan-Mar; revenue at Rs 161 cr

Lincoln Pharmaceuticals on Thursday reported a net profit of Rs 11.62 crore for the March quarter of 2024-25 and said it is building a portfolio in lifestyle and chronic segments, particularly in women's healthcare and dermatology. The Ahmedabad-based company in a statement said that it focuses on expanding its global footprint by registering new products for export and also building a portfolio in lifestyle and chronic segments. The pharma company had reported a net profit of Rs 18.8 crore in the year-ago period. Revenue from operations rose to Rs 161.30 crore in the last quarter of FY25 from Rs 149.51 crore in the year-ago period. "The company remain committed to net debt-free and continues to leverage strategic product launches in both domestic and international markets to strengthen our market presence," Lincoln Pharmaceuticals Managing Director Mahendra Patel said. For the full fiscal, the company reported a net profit of Rs 82.44 crore against Rs 93.36 crore in FY24. Total .

Interarch Building Solutions Q4 results: Profit rises 30% to Rs 39 crore

Interarch Building Solutions has posted a 30 per cent increase in its net profit to Rs 38.68 crore for the fourth quarter of the last financial year on higher revenue. Its net profit stood at Rs 29.69 crore in the year-ago period. The total income of Interarch Building Solutions, which is in the Pre-Engineered Building (PEB) industry, rose to Rs 470.58 crore in the January-March period of 2024-25 from Rs 390.23 crore in the corresponding period of the preceding fiscal. During the full 2024-25 fiscal, the company's net profit increased to Rs 107.82 crore from Rs 86.26 crore a year ago, it said in a regulatory filing on Wednesday. Its total income grew to Rs 1,474.47 crore last fiscal, from Rs 1,306.31 crore in 2023-24. Commenting on the company's performance, Interarch Building Solutions Ltd Managing Director Arvind Nanda said the company has reported the highest-ever quarterly and annual financial performance, marked by robust volume growth and improved order execution. "The ...

Why Sensex fell 1000pts, Nifty below 24,550 on May 22? Check reasons here

The BSE Sensex fell as much as 1.06 per cent or 869.52 points to 80,727.11. Similarly, the NSE Nifty50 dropped 1.09 per cent or 361.85 points to 24,541.60.

ONGC Q4 results: Net profit falls 35% to ₹6,448 cr on lower oil, gas prices

State-owned Oil and Natural Gas Corporation (ONGC) reported a 35 per cent drop in its March quarter net profit as it realised lower oil prices on almost static output. Net profit stood at Rs 6,448 crore in January-March - the fourth quarter of FY25 (April 2024 to March 2025 ) - compared to Rs 9,869 crore in the same period last year, according to a company statement. The firm got USD 73.72 per barrel of crude oil that it produced and sold to refiners for processing into petrol and diesel in the fourth quarter, down from USD 80.81 per barrel a year back. Revenue was up 1 per cent at Rs 34,982 crore. ONGC produced 4.7 million tonnes of crude oil in the quarter, marginally lower than 4.714 million tonnes in January-March 2024. Production of natural gas, which is used to generate electricity, make fertiliser and turned into CNG as well as used for cooking in kitchens, was lower at 4.893 Billion Cubic Metres (BCM) in Q4 as opposed to 4.951 BCM. For the full fiscal (FY25), ONGC's net p

Fortis Healthcare rallies 9%, nears record high; brokerages see more upside

The stock price of Fortis Healthcare is quoting at ₹731.35, its highest level since January 8, 2025, and inching towards its record high level of ₹744, touched on December 30, 2024.

ONGC shares slip 2% on posting mixed Q4 nos; PAT down 22% QoQ, Rev up 4%

ONGC share price declined 2 per cent after company posted mixed Q4FY25 numbers

Smallcap stock hits record high in weak market; rallies 69% thus far in May

Shares of Timex Group India, one of India's leading watchmakers, and part of the US-headquartered iconic Timex Group, hit a record high of ₹264.20

NTPC Green share price zooms 12% on posting 188% rise in Q4 PAT YoY

NTPC Green Energy shares jump 12 per cent as the company posts healthy Q4 numbers

Q4 results today: ITC, Sun Pharma, GMR Airports on May 22; see full list

Q4 FY25 company results today: Emcure Pharmaceuticals, Honasa Consumers, and Reliance Home Finance will be among 164 companies to post earnings reports for the January-March quarter on May 22

Jio Platforms finds the right signal with 'non-connectivity' ventures

At an annualised level, revenues from non-connectivity services are expected to reach about ₹16,000 crore

IndiGo Q4 results: Profit rises 62% on Mahakumbh demand, cost controls

Q4 profit rises to Rs 3,068 crore as travel demand surges; IndiGo trims grounded fleet and adds capacity, set to launch long-haul service to Manchester in July

Oil India Q4 results: Profit drops 39% to ₹1,310 cr on lower crude prices

Despite a 39 per cent drop in profit, Oil India posted record FY25 production and 123 per cent rise in capex utilisation; Q4 revenue slipped 5.7 per cent

Geojit Financial Services Q4 results: Net profit down 38% at Rs 32.21 cr

Geojit Financial Services on Wednesday reported a 38 per cent decline in consolidated net profit at Rs 32.21 crore in the March 2025 quarter compared to a profit of Rs 51.91 crore in the year-ago period. Total consolidated revenue declined by 15 per cent to Rs 177.48 crore in the last quarter of 2024-25 as compared with Rs 208.56 crore in the same period of the preceding fiscal, the company said in a filing to the stock exchanges. On a sequential basis, revenue of the company rose marginally from Rs 172.11 crore in the December quarter. Operating profit, measured as earnings before interest, taxes, depreciation and amortisation (EBITDA) dropped 35 per cent year-on-year to Rs 54.09 crore in the fourth quarter, compared to Rs 83.36 crore in the year-ago quarter. During the financial year 2024-25, the company, however, reported improved performance. The consolidated revenue rose 20 per cent year-on-year to Rs 749.32 crore, while net profit grew 15 per cent to Rs 172.49 crore. The ...

PFC Q4 results: Profit rises 11% to ₹8,358 crore on interest income gains

PFC posts 11 per cent YoY profit rise in Q4 FY25; interest income and loan growth drive earnings; asset quality improves and renewable book rises 35 per cent

Oil India Q4 results: Profit declines 39% to ₹1,310 cr, dividend declared

Oil India's board of directors have recommended a final dividend of ₹1.50 per equity share, subject to the approval of the company

With 1st quarterly loss in 19 yrs, IndusInd vows to clean up mess

Bank expects to propose CEO names much ahead of June 30 deadline